Detalhe da pesquisa
1.
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.
Blood
; 139(9): 1340-1358, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788382
2.
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia.
Blood Adv
; 5(16): 3152-3162, 2021 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424320
3.
ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia.
Leuk Res
; 118: 106872, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640397